The Global (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market was valued at USD 28.4 Million in 2025 and is projected to reach USD 52.6 Million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. This growth is being driven by rising demand for enantiopure intermediates in pharmaceutical manufacturing, expanding applications in asymmetric synthesis, and the increasing regulatory emphasis on single-enantiomer drug formulations across therapeutic areas such as cardiovascular and antiviral medicines.

As the pharmaceutical industry continues to prioritize chiral purity for improved efficacy and safety profiles, the spotlight is on the key suppliers and manufacturers who are driving innovation, quality consistency, and scalable production of high-purity chiral building blocks. In this blog, we profile the Top 10 Companies in the (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market—a mix of specialty fine chemical producers, catalog suppliers, and chiral reagent manufacturers shaping the future of enantioselective synthesis and API development.

---

🔟 1. Sigma-Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany
Key Offering: High-purity (2R)-(-)-Glycidyl tosylate (≥98% ee), research-grade chiral reagents

Sigma-Aldrich, part of Merck KGaA, is a global leader in supplying high-quality chiral intermediates and reagents for laboratory and industrial research. The company offers (2R)-(-)-Glycidyl tosylate with stringent quality specifications suitable for asymmetric synthesis and pharmaceutical process development, serving academic institutions, CROs, and API manufacturers worldwide.

Quality & Innovation Initiatives:

• Comprehensive analytical documentation including chiral HPLC and optical rotation data

• Support for scalable synthesis through custom packaging and bulk options

• Commitment to sustainable chemical sourcing and green chemistry practices

Download FREE Sample Report: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

---

9️⃣ 2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: (2R)-(-)-Glycidyl tosylate, enantiopure chiral epoxides and tosylates

TCI Chemicals is recognized for its extensive catalog of high-purity specialty chemicals and chiral building blocks. The company supplies (2R)-(-)-Glycidyl tosylate to researchers and manufacturers focused on stereoselective transformations, with a strong emphasis on optical purity and batch-to-batch consistency for pharmaceutical applications.

Quality & Innovation Initiatives:

• Investment in advanced chiral separation technologies

• Global distribution network supporting rapid delivery to R&D labs

• Collaboration with academic partners on novel synthetic methodologies

---

8️⃣ 3. Jiangsu Aikon Biopharmaceutical R&D Co., Ltd.

Headquarters: Jiangsu, China
Key Offering: Pharmaceutical-grade (2R)-(-)-Glycidyl tosylate, custom chiral intermediates

Jiangsu Aikon has established itself as a capable producer of chiral glycidyl derivatives, leveraging cost-effective manufacturing platforms in China to serve both domestic and international pharmaceutical clients. The company focuses on scaling production while maintaining high enantiomeric excess for use in beta-blocker and antiviral intermediate synthesis.

Quality & Innovation Initiatives:

• Expansion of GMP-compliant production capabilities

• Development of efficient asymmetric synthesis routes

• Strategic partnerships with global CDMOs

Download FREE Sample Report: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

---

7️⃣ 4. Shanghai Sinofluoro Scientific Co., Ltd.

Headquarters: Shanghai, China
Key Offering: High-purity (2R)-(-)-Glycidyl tosylate and fluorinated chiral building blocks

Shanghai Sinofluoro specializes in advanced chiral and fluorinated compounds, supplying (2R)-(-)-Glycidyl tosylate for precision organic synthesis. Their products support the preparation of enantiomerically enriched APIs, with particular strength in serving mid-to-large scale pharmaceutical development projects.

Quality & Innovation Initiatives:

• Focus on multi-step chiral synthesis optimization

• Investment in analytical instrumentation for purity verification

• Expansion into custom synthesis services for specialty pharma

---

6️⃣ 5. Nanjing Chemlin Chemical Industry Co., Ltd.

Headquarters: Nanjing, China
Key Offering: (2R)-(-)-Glycidyl tosylate, bulk chiral intermediates for API synthesis

Nanjing Chemlin is a prominent fine chemical manufacturer offering reliable supply of (2R)-(-)-Glycidyl tosylate to support industrial-scale production of chiral pharmaceuticals. The company emphasizes consistent quality and competitive pricing for contract manufacturing clients.

Quality & Innovation Initiatives:

• Scalable production from pilot to commercial quantities

• Process chemistry improvements for higher yields

• Compliance support for international regulatory standards

---

5️⃣ 6. Hairui Chemical

Headquarters: China
Key Offering: Enantiopure glycidyl tosylates and related chiral synthons

Hairui Chemical has grown its presence in the chiral intermediates space by providing high-quality (2R)-(-)-Glycidyl tosylate suitable for research and development as well as commercial API routes. Their offerings cater to both catalog buyers and dedicated synthesis partners.

Quality & Innovation Initiatives:

• Continuous improvement in enantiomeric purity control

• Development of greener synthetic alternatives

• Customer-focused technical support services

Download FREE Sample Report: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

---

4️⃣ 7. Suzhou Rovathin Pharmaceutical Technology Co., Ltd.

Headquarters: Suzhou, China
Key Offering: Custom-synthesized (2R)-(-)-Glycidyl tosylate and pharmaceutical intermediates

Suzhou Rovathin focuses on pharmaceutical technology and custom synthesis, delivering (2R)-(-)-Glycidyl tosylate as part of broader chiral building block portfolios. The company supports innovators in developing next-generation chiral drugs through flexible manufacturing solutions.

Quality & Innovation Initiatives:

• Specialization in complex multi-chiral center synthesis

• Strong R&D capabilities for process optimization

• Emphasis on IP protection and confidentiality

---

3️⃣ 8. Combi-Blocks Inc.

Headquarters: San Diego, California, USA
Key Offering: Research and bulk quantities of (2R)-(-)-Glycidyl tosylate

Combi-Blocks is a trusted U.S.-based supplier of building blocks for medicinal chemistry and drug discovery. They provide (2R)-(-)-Glycidyl tosylate with detailed product specifications, serving laboratories engaged in the synthesis of beta-blockers and other chiral APIs.

Quality & Innovation Initiatives:

• Curated selection of enantiopure reagents

• Fast response to custom synthesis inquiries

• Support for early-stage drug discovery programs

---

2️⃣ 9. Oakwood Chemical

Headquarters: Estill, South Carolina, USA
Key Offering: High-purity chiral compounds including (2R)-(-)-Glycidyl tosylate

Oakwood Chemical supplies a wide range of specialty organics and chiral reagents to the North American market. Their (2R)-(-)-Glycidyl tosylate is valued for its reliability in stereospecific reactions and compatibility with established pharmaceutical synthesis protocols.

Quality & Innovation Initiatives:

• Rigorous in-house quality control standards

• Expansion of catalog offerings for chiral chemistry

• Technical expertise in handling sensitive epoxides

Download FREE Sample Report: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

---

1️⃣ 10. Bld Pharmatech Ltd.

Headquarters: Shanghai, China
Key Offering: (2R)-(-)-Glycidyl tosylate with cold-chain and custom options

Bld Pharm offers efficient sourcing solutions for chiral intermediates, including (2R)-(-)-Glycidyl tosylate. The company supports global clients with competitive supply chains and attention to handling requirements critical for maintaining compound stability.

Quality & Innovation Initiatives:

• Optimized logistics for moisture-sensitive materials

• Broad portfolio of glycidyl derivatives

• Focus on customer-centric supply reliability

Get Full Report Here: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

---

🌍 Outlook: The Future of (2R)-(-)-Glycidyl tosylate Is Precision-Driven and Scalable

The (2R)-(-)-Glycidyl tosylate market is experiencing measured expansion as pharmaceutical developers seek reliable chiral building blocks for complex molecule assembly. While research-grade demand remains steady, commercial opportunities are growing with the maturation of chiral API pipelines and the globalization of fine chemical manufacturing.

📈 Key Trends Shaping the Market:

• Increasing adoption of high-purity grades for regulated pharmaceutical processes

• Growth of contract manufacturing in Asia-Pacific supporting cost-efficient scale-up

• Advancements in analytical techniques ensuring consistent enantiomeric excess

• Collaborations between reagent suppliers and CDMOs to streamline chiral intermediate supply

Get Full Report Here: (2R)-(-)-Glycidyl tosylate (CAS No. 113826-06-5) Market – View in Detailed Research Report

The companies listed above are not only supplying a critical chiral reagent—they are enabling the precise molecular construction that defines modern pharmaceutical innovation.